IFP Advisors
RLAY icon

IFP Advisors’s Relay Therapeutics RLAY Stock Holding History

IFP Advisors’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$10.2K Hold
563
– – ﹤0.01% 3377
2026
Q2 		$10.5K Sell
563
-13
-2% -$189 ﹤0.01% 3365
2026
Q1 		$5.73K Hold
576
– – ﹤0.01% 3438
2025
Q4 		$4.87K Hold
576
– – ﹤0.01% 3427
2025
Q3 		$3.01K Buy
576
+407
+241% +$1.55K ﹤0.01% 3518
2025
Q2 		$585 Buy
+169
New +$503 ﹤0.01% 4392
2025
Q1 		– Hold
0
– – – 4177
2024
Q4 		– Hold
0
– – – 4390

Other funds holding RLAY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 42.55% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.23B AUM 121.47% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Spruce Street Capital
Spruce Street Capital New York $629M AUM 210.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

IFP Advisors's RLAY Position: Q3 2026 in Review

IFP Advisors held its Relay Therapeutics (RLAY) position steady in Q3 2026 at 563 shares worth $10.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3377.

IFP Advisors first reported a position in RLAY in Q2 2025 and has held it in 6 quarters since. The position peaked at $10.5K in Q2 2026. 183 funds tracked by Wall St. Rank hold RLAY as of Q3 2026.

  • IFP Advisors held 563 shares of Relay Therapeutics worth $10.2K as of Q3 2026.
  • IFP Advisors left its Relay Therapeutics share count unchanged in Q3 2026.
  • Relay Therapeutics made up ﹤0.01% of IFP Advisors's portfolio in Q3 2026, its #3377 holding.
  • IFP Advisors first reported a position in Relay Therapeutics in Q2 2025 and has held it in 6 quarters since.
  • IFP Advisors's Relay Therapeutics position peaked at $10.5K in Q2 2026.
  • 183 funds tracked by Wall St. Rank held Relay Therapeutics as of Q3 2026.

Based on IFP Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.